Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-20
DOI
10.1038/s41598-021-90187-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anthropometer3D: Automatic Multi-Slice Segmentation Software for the Measurement of Anthropometric Parameters from CT of PET/CT
- (2019) Pierre Decazes et al. JOURNAL OF DIGITAL IMAGING
- Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer
- (2018) Ricard Ramos et al. EJSO
- Quantifying the effect of slice thickness, intravenous contrast and tube current on muscle segmentation: Implications for body composition analysis
- (2018) Georg Fuchs et al. EUROPEAN RADIOLOGY
- Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer
- (2018) Yukinori Matsuo et al. Journal of Geriatric Oncology
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
- (2015) Jeffrey D Bradley et al. LANCET ONCOLOGY
- Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer
- (2015) Se-Il Go et al. SUPPORTIVE CARE IN CANCER
- Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
- (2014) Guro B. Stene et al. ACTA ONCOLOGICA
- The assessment and impact of sarcopenia in lung cancer: a systematic literature review
- (2014) Jemima Collins et al. BMJ Open
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
- (2010) Y Wu et al. BRITISH JOURNAL OF CANCER
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started